about
sameAs
Improving the extent of malignant glioma resection by dual intraoperative visualization approachSurvival motor neuron gene 2 silencing by DNA methylation correlates with spinal muscular atrophy disease severity and can be bypassed by histone deacetylase inhibitionSurgical resection of malignant gliomas-role in optimizing patient outcome.Histone deacetylase inhibitors: possible implications for neurodegenerative disorders.xCT modulation in gliomas: relevance to energy metabolism and tumor microenvironment normalization.Brain miffed by macrophage migration inhibitory factor.Myocutaneous propeller flap based on the superior gluteal artery (SGA) for closure of large lumbosacral meningomyelocoele defects: a case report.Dynamic contrast enhancement of experimental glioma an intra-individual comparative study to assess the optimal time delay.Small interfering RNA-mediated xCT silencing in gliomas inhibits neurodegeneration and alleviates brain edema.The peroxisome proliferator-activated receptor-gamma agonist troglitazone inhibits transforming growth factor-beta-mediated glioma cell migration and brain invasion.Ex vivo therapy of malignant melanomas transplanted into organotypic brain slice cultures using inhibitors of histone deacetylases.Suberoylanilide hydroxamic acid (SAHA) has potent anti-glioma properties in vitro, ex vivo and in vivo.Identification of neuronal cell death in a model of degeneration in the hippocampus.Selenium deficiency increases susceptibility to glutamate-induced excitotoxicity.Ultrasound-guided neuronavigation improves safety of ventricular catheter insertion in preterm infants.Cellular characterization of the peritumoral edema zone in malignant brain tumors.The sitting position in neurosurgery: indications, complications and results. a single institution experience of 600 cases.The x(c)(-) cystine/glutamate antiporter (xCT) as a potential target for therapy of cancer: yet another cytotoxic anticancer approach?Malignant glioma-induced neuronal cell death in an organotypic glioma invasion model. Technical note.Bone marrow-derived cells expressing green fluorescent protein under the control of the glial fibrillary acidic protein promoter do not differentiate into astrocytes in vitro and in vivo.Modification of microglia function protects from lesion-induced neuronal alterations and promotes sprouting in the hippocampus.In vivo micro-CT imaging of rat brain glioma: a comparison with 3T MRI and histology.Histone deacetylase inhibitors increase neuronal differentiation in adult forebrain precursor cells.In vitro and ex vivo evaluation of second-generation histone deacetylase inhibitors for the treatment of spinal muscular atrophy.Experimental therapy of malignant gliomas using the inhibitor of histone deacetylase MS-275.High resolution neurochemical gold staining method for myelin in peripheral and central nervous system at the light- and electron-microscopic level.Lessons from the bone marrow: how malignant glioma cells attract adult haematopoietic progenitor cells.Clinical evaluation of flat-panel detector compared with multislice computed tomography in 65 patients with acute intracranial hemorrhage: initial results. Clinical article.Common mutations of beta-catenin in adamantinomatous craniopharyngiomas but not in other tumours originating from the sellar region.Abundant hypermethylation of SOCS-1 in clinically silent pituitary adenomas
P50
Q21090866-F7576321-B094-4761-B97D-478FAB8AA539Q24655533-A8BD3043-44E3-4273-82AD-967314418218Q34324963-E375AA64-1B02-4396-8C3A-F2E462A1CA1CQ34743081-65D0AE59-B588-4AD1-A476-2435EA754E13Q37783819-DDB7039B-AAA7-423B-9D2D-F691717ED488Q38042932-916C7672-2B07-4FC6-8868-F862B28BC803Q39713585-5DFF03F0-9BB6-4175-93C0-EA62CB4D5DC3Q39775548-E5FBAA5D-CBC2-444C-8CA9-B38C631D5EA8Q39983715-168A513A-35B1-44BF-ADE3-E7E717E94A15Q40125579-F7020144-D941-4B88-83F0-E7212A5DD88FQ40268068-4DC5E2DA-1BD8-4289-9716-F06F2717B926Q40430014-AFFF56B3-4D55-4AEF-A910-A57A2C5EE12DQ40655278-1A843A25-77AD-4839-8049-83AAD9FB47EFQ40691222-3AA2B5D8-5754-482D-8834-48D42593867BQ43594569-60C255E0-28A4-47C4-84CE-53A69A22E63BQ43917622-FCDD0295-5B57-493F-B29F-190A1DC43DF0Q45737514-E65D93D5-865D-4AFE-BD3B-A6F9A1E0D052Q46025421-01BF8965-E303-45F5-B54F-B8435850C7A5Q46472298-925A8E3E-F63D-4774-A496-F61BCF1F0584Q47795942-11AC3BD3-0B71-430D-998C-A529696445C6Q47977925-BC86AA17-25B1-4E50-BFD0-FD4999E51198Q47979009-A20821A6-A2D3-45DD-B0EE-7B40ABC7128DQ48313424-AB8170B6-E4A5-4F38-A58E-0414BD0CE851Q48485610-D4069A9E-F1C4-4A9A-B188-863C0C506453Q48519096-7D4A1534-F1CF-4C6D-AC23-E7BBE9295836Q48578558-9F62EB09-410A-49EF-A984-975156F8351EQ48860634-CE51C66E-0985-42CD-B652-67C55908B28CQ53305013-AAD8C04C-127E-4A70-8868-6F8CA9918DBDQ53358086-B653339B-A589-4E6C-8B53-FC5D85E061CEQ82299441-AE8B4B59-5142-46FF-A231-D7D78C267465
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Ilker Y Eyüpoglu
@ast
Ilker Y Eyüpoglu
@en
Ilker Y Eyüpoglu
@es
Ilker Y Eyüpoglu
@nl
Ilker Y Eyüpoglu
@sl
type
label
Ilker Y Eyüpoglu
@ast
Ilker Y Eyüpoglu
@en
Ilker Y Eyüpoglu
@es
Ilker Y Eyüpoglu
@nl
Ilker Y Eyüpoglu
@sl
prefLabel
Ilker Y Eyüpoglu
@ast
Ilker Y Eyüpoglu
@en
Ilker Y Eyüpoglu
@es
Ilker Y Eyüpoglu
@nl
Ilker Y Eyüpoglu
@sl
P106
P21
P31
P496
0000-0002-8185-7764